Comparative analysis of pembrolizumab and cetuximab-based therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma: Real-world data

被引：0
|
作者：
Hamedi, Zahra
Lo, Andrea Yachee
Berkman, Jonathan David
Alesi, Erin R.
机构：
[1] Virginia Commonwealth Univ Hlth Syst, Div Hematol Oncol & Palliat Care, Massey Comprehens Canc Ctr, Richmond, VA USA
[2] Virginia Commonwealth Univ Hlth Syst, Dept Internal Med, Richmond, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6022
引用
收藏
页数：1
相关论文
共 50 条
  • [21] High Response Rate to Carboplatin-Paclitaxel-Cetuximab and Pembrolizumab in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
    Chauffert, Bruno
    Zhou, Yuedan
    Medjkoune, Liza
    Ouikene, Abdenour
    Galez, Agnes
    Belkhir, Farid
    Saint-Germain, Pierre
    Youssef, Ali
    Chehimi, Mohamad
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 13 - 20
  • [22] Outcome of patients with recurrent/metastatic squamous cell head and neck cancer treated with platinum-based chemotherapy with or without cetuximab in real-world practice
    Zupancic, Tina
    Zakotnik, Branko
    Kuhar, Cvetka Grasic
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 15 (03)
  • [23] Weekly Cetuximab and Paclitaxel for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Fushimi, Chihiro
    Baba, Daisuke
    Masubuchi, Tatsuo
    Yamazaki, Morio
    Kitani, Yosuke
    Kitajima, Tatsuya
    Tanaka, Junpei
    Hanyu, Kenji
    Tanaka, Naruhisa
    Miura, Kouki
    Tada, Yuichiro
    IN VIVO, 2020, 34 (05): : 2653 - 2657
  • [24] Simlukafusp a and cetuximab combination in patients with recurrent, unresectable or metastatic squamous cell carcinoma of the head and neck
    Hansen, A. R.
    Gomez-Roca, C. A.
    Lolkema, M. P.
    Verlingue, L.
    Italiano, A.
    Spicer, J.
    Steeghs, N.
    Bauman, J. E.
    Fayette, J.
    Niu, J.
    Prenen, H.
    Dejardin, D.
    Boetsch, C.
    Kraxner, A.
    Evers, S.
    Vardar, T.
    Keshelava, N.
    Teichgraber, V.
    Bonomi, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S805 - S805
  • [25] Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population
    Chen, Wen-Chun
    Chu, Pen-Yuan
    Lee, Yu-Ting
    Lu, Wen-Bin
    Liu, Chun-Yu
    Chang, Peter Mu-Hsin
    Yang, Muh-Hwa
    MEDICINE, 2017, 96 (52)
  • [26] The potential for local ablative therapy of oligometastases in head and neck squamous cell carcinoma: a real-world data analysis
    Kjems, Julie
    Laursen, Michael R. T.
    Kristensen, Claus A.
    Gothelf, Anita B.
    Bernsdorf, Mogens
    Specht, Lena
    Berthelsen, Anne K.
    Vogelius, Ivan R.
    Persson, Gitte F.
    Friborg, Jeppe
    ACTA ONCOLOGICA, 2023, 62 (09) : 1091 - 1095
  • [27] Real-world outcomes for patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab
    Singh, P.
    You, M.
    Lubinga, S.
    Zhang, Y.
    ANNALS OF ONCOLOGY, 2019, 30
  • [28] Real-world evidence of first-line cetuximab (CX) plus paclitaxel (PX) in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)
    Cirauqui Cirauqui, B.
    Martinez Trufero, J.
    Plana Serrahima, M.
    Garcia Castano, A.
    Rubio-Casadevall, J.
    Carral Maseda, A.
    Iglesias Docampo, L.
    Perez Segura, P.
    Ceballos Lenza, I.
    Gutierrez Calderon, V.
    Fuster Salva, J.
    Pena Alvarez, C.
    Arrazubi Arrula, V.
    del Barco Morillo, E.
    Chaves Conde, M.
    Martinez Galan, J.
    Duran Sanchez, M.
    Quiroga, V.
    Ortega, E.
    Mesia Nin, R.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S852 - S853
  • [29] Real-World Time on Treatment Analysis of Pembrolizumab Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Patients Stratified by ECOG PS in the United States
    Black, C.
    Wang, L.
    Ramakrishnan, K.
    Turzhitsky, V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E342 - E342
  • [30] Managing recurrent/metastatic head and neck cancer in the real-world: Paclitaxel plus Cetuximab
    Leao, I.
    Neto, R.
    Marinho, J.
    Neto, E.
    Dias, E.
    Joaquim, A.
    RADIOTHERAPY AND ONCOLOGY, 2019, 132 : 51 - 51
12345